MedTrace Logo

Assessing Hp Diagnosis and Treatment Quality of direct-to Consumer Telemedicine in Mainland China

NCT06749873 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 552

Last updated 2025-02-19

No results posted yet for this study

Summary

A quality assessment of the level of H. pylori diagnosis and treatment in mainland China's Direct-to-consumer telemedicine (DTCT) was conducted by means of Unannounced standardized patients (USPs).

Conditions

  • Helicobacter Pylori Infection

Interventions

OTHER

Background of different SP information

Sp was asked with the following baseline information: 1. 50 years of age and gender; 2. positive urea breath test; 3. asymptomatic; 4. family history of gastric cancer; 5. gastroscopy: atrophic gastritis; 6. untreated; and 7. no history of drug allergies.

Sponsors & Collaborators

  • Shandong University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-01
Primary Completion
2025-01-31
Completion
2025-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06749873 on ClinicalTrials.gov